1,107 results on '"Cobo, M."'
Search Results
2. Designing and Evaluating Personalized Learning Itineraries: An Experience at the University
3. Living between sand and waves: Age and feeding habits of sand sole (Pegusa lascaris, Risso 1810) and brill (Scophthalmus rhombus, Linnaeus, 1758) on the beaches of the Gulf of Cádiz (Southwest Iberian Peninsula)
4. Identification of hazardous organic compounds in e-waste plastic using non-target and suspect screening approaches
5. International Environmental Standards for the Regulation of Freshwater Cyanobacterial Blooms and Their Biotoxins
6. Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
7. Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1
8. Why do papers from international collaborations get more citations? A bibliometric analysis of Library and Information Science papers
9. Recent findings of the deep–sea fish species Tetragonurus cuvieri Risso, 1810 and Notacanthus bonaparte Risso, 1840 (Chordata, Teleostei) in Southwestern Europe (Gulf of Cádiz, SW Spain)
10. TTFields (Tumor Treating Fields) associés au traitement standard dans les cancers du poumon non à petites cellules métastatiques en progression après platine : étude internationale, randomisée de phase 3 LUNAR
11. First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update
12. 30th Anniversary of Applied Intelligence: A combination of bibliometrics and thematic analysis using SciMAT
13. Micromenia amphiatlantica sp. nov.: First solenogaster (Mollusca, Aplacophora) with an amphi-Atlantic distribution and insight into abyssal solenogaster diversity
14. EP08.03-01 Copy Number Variants and Late Somatic Mutations Underlying Tumor Progression in NADIM Clinical Trials
15. OA22.05 TTFields and Immune-Checkpoint Inhibitor in Metastatic Non-Small Cell Lung Cancer: PD-L1 Subgroups in the Phase 3 LUNAR Study
16. MA03.11 Big Data and Artificial Intelligence for Exploring the Role of Genetic Risk. Family History of Cancer and Lung Cancer. Results from CLARIFY
17. P1.21-02 Genetic Susceptibility to Immune Checkpoints Blockade Resistance
18. P1.01-04 Clinical and Genetic Characteristics in Younger vs Older Lung Cancer Patients
19. P1.27-07 BRAF Mutations Identify Non-small-Cell Lung Cancer Patients Who Benefit from Neoadjuvant Chemo-Immunotherapy
20. P2.05-13 Canakinumab with Standard of Care for Patients with Advanced NSCLC: T-cell Infiltration Analysis in CANOPY-1
21. Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
22. Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1
23. Expression-based, consistent biomarkers for prognosis and diagnosis in lung cancer
24. SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019)
25. Visualization and Evolution of the Scientific Structure of Fuzzy Sets Research in Spain
26. Measuring the Impact of the International Relationships of the Andalusian Universities Using Dimensions Database
27. Constructing Bibliometric Networks from Spanish Doctoral Theses
28. Cantor Singular Continuous Spectrum for Operators Along Interval Exchange Transformations
29. Factores asociados al ataque cerebrovascular isquémico entre los años 2013 a 2016: estudio de casos y controles
30. Lowering bronchoaspiration rate in an acute stroke unit by means of a 2 volume/3 texture dysphagia screening test with pulsioximetry
31. Reducción de la tasa de broncoaspiración con el test 2 volúmenes/3 texturas con pulsioximetría en una unidad de ictus
32. Some bibliometric procedures for analyzing and evaluating research fields
33. Principles and orientations for media users’ ethics: contributions from the side of the Catholic Church’s Social Teaching
34. Spotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activity
35. Four new Solenogastres (Mollusca, Aplacophora) from the South China Sea and paraphyly of Proneomeniidae Simroth, 1893
36. Constructing Bibliometric Networks from Spanish Doctoral Theses
37. Measuring the Impact of the International Relationships of the Andalusian Universities Using Dimensions Database
38. Recomendaciones para el diagnóstico radiológico y la valoración de la respuesta terapéutica en el cáncer de pulmón. Consenso nacional de la Sociedad Española de Radiología Médica y la Sociedad Española de Oncología Médica
39. Uncovering the biodiversity of New Zealand Solenogastres (Mollusca, Aplacophora) with three new species of Proneomeniidae Simroth, 1893 and new data for Dorymenia quincarinata (Ponder, 1970)
40. Musica y oralidad como formas de arqueologia literaria: memorias silenciadas de la esclavitud
41. 22 Years of Lean Supply Chain Management: a science mapping-based bibliometric analysis.
42. Obtaining Homogeneous Regions by Determining the Generalized Fractal Dimensions of Validated Daily Rainfall Data Sets
43. A consensus statement on the gender perspective in lung cancer
44. Long-term survival in advanced non-squamous NSCLC patients treated with first-line bevacizumab-based therapy
45. Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies
46. Estimation of cyanobacteria biovolume in water reservoirs by MERIS sensor
47. Consensual Processes Based on Mobile Technologies and Dynamic Information
48. Applying Linguistic OWA Operators in Consensus Models under Unbalanced Linguistic Information
49. PL03.12 Progression Free Survival and Overall Survival in NADIM II Study
50. P1.15-09 First-line Atezolizumab plus Bevacizumab for Metastatic High-Intermediate TMB in Non-squamous NSCLC. The TELMA Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.